Hepatitis B vaccination: Risk-benefit pr
โ
Tom Jefferson; Giuseppe Traversa
๐
Article
๐
2002
๐
John Wiley and Sons
๐
English
โ 50 KB
## Abstract Since the early 1990s, several cases of demyelinating diseases were reported in France in association with the vaccination against hepatitis B. A large scientific, regulatory, and public debate took place to reassure the growing concern of the population. The objective of this paper is